Moderate-to-High Levels of Pretreatment HIV Drug Resistance in KwaZulu-Natal Province, South Africa
- 1 February 2019
- journal article
- research article
- Published by SAGE Publications in AIDS Research and Human Retroviruses
- Vol. 35 (2) , 129-138
Abstract
There is evidence of increasing levels of pretreatment HIV drug resistance (PDR) in Southern Africa. We used data from two large population-based HIV surveillance studies to estimate prevalence of PDR in KwaZulu-Natal, the province with the highest HIV prevalence in South Africa. Sanger sequencing was performed on samples obtained from a longitudinal HIV surveillance program (study A, 2013–2014) and the HIV Incidence Provincial Surveillance System (study B, 2014–2015). Sequences were included for adult HIV positive participants (age ≥15 years for study A, age 15–49 years for study B) with no documented prior exposure to antiretroviral therapy (ART). Overall and drug class-specific PDR was estimated using the World Health Organization 2009 surveillance drug resistance mutation (SDRM) list, and phylogenetic analysis was performed to establish evidence of drug resistance transmission linkage. A total of 1,845 sequences were analyzed (611 study A; 1,234 study B). An overall PDR prevalence of 9.2% [95% confidence interval (CI) 7.0–11.7] was observed for study A and 11.0% (95% CI 8.9–13.2) for study B. In study B, the prevalence of non-nucleoside reverse-transcriptase inhibitor (NNRTI) PDR exceeded 10% for sequences collected in 2014 (10.2%, 95% CI 7.5–12.9). The most prevalent SDRMs were K103NS (7.5%), M184VI (2.4%), and V106AM (1.4%). There was no evidence of large transmission chains of drug-resistant virus. High level NNRTI PDR (>10%) suggests a need to modify the standard first-line ART regimen and to focus attention on improving the quality of HIV prevention, treatment, and care.Keywords
This publication has 44 references indexed in Scilit:
- Automated analysis of phylogenetic clustersBMC Bioinformatics, 2013
- Primary Drug Resistance in South Africa: Data from 10 Years of SurveysAIDS Research and Human Retroviruses, 2012
- Surveillance of Transmitted HIV-1 Drug Resistance in Gauteng and KwaZulu-Natal Provinces, South Africa, 2005–2009Clinical Infectious Diseases, 2012
- Evaluation of In-house Genotyping Assay Performance Using Dried Blood Spot Specimens in the Global World Health Organization Laboratory NetworkClinical Infectious Diseases, 2012
- FastTree 2 – Approximately Maximum-Likelihood Trees for Large AlignmentsPLOS ONE, 2010
- Cohort Profile: Hlabisa HIV Treatment and Care ProgrammeInternational Journal of Epidemiology, 2010
- The calibrated population resistance tool: standardized genotypic estimation of transmitted HIV-1 drug resistanceBioinformatics, 2009
- Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 UpdatePLOS ONE, 2009
- Cohort Profile: Africa Centre Demographic Information System (ACDIS) and population-based HIV surveyInternational Journal of Epidemiology, 2007
- HIV-1 protease and reverse transcriptase mutations for drug resistance surveillanceAIDS, 2007